Sign up for the QMED & MD+DI Daily newsletter.
AdvaMed Praises New Version of Disclosure Bill
AdvaMed said it supports the changes recently made to a Senate bill on disclosure to patients of doctors' financial ties to drug and device companies. "This bill is an important step forward in improving transparency and does so in a manner that does not jeopardize future innovation. That’s good news for patients, physicians and industry," said Stephen J.
May 22, 2008
1 Min Read
.svg?width=1280&auto=webp&quality=95&format=jpg&disable=upscale "AdvaMed Praises New Version of Disclosure Bill")
Ubl, president and CEO of AdvaMed.The modifications include preemption of state disclosure laws to ensure consistency; requiring compliance by physician-owned manufacturers, distributors, and group purchasing organizations; and requiring disclosure information to be displayed in an easy-to-understand manner. AdvaMed would like to see one more change: exempting companies who pay less than $250,000 per year to physicians.
You May Also Like
.png?width=700&auto=webp&quality=80&disable=upscale)
